Dexin Yu

Dexin Yu

Auto-generated profile, based on publicly available information

Dexin Yu

Department of Urology, The Second Affiliated Hospital of Anhui Medical University, Hefei, China

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 November 2017 in Biochemical and Biophysical Research Communications
Verified
Journal Article
Closed access
DWDengdian Wang
Dengdian Wang
XKXiaochuan Kong
Xiaochuan Kong
YLYuan Li
Yuan Li
WQWeiwei Qian
Weiwei Qian
JMJiaxing Ma
Jiaxing Ma
CZCaiyun Zhong
Caiyun Zhong

16 February 2016 in Oncology Reports
Verified
Journal Article
Open access
PDF file
Qifei DengQifei Deng
Qifei Deng
XSXin Sun
Xin Sun
ZLZhaofeng Liang
Zhaofeng Liang
ZZZhi-Qiang Zhang
Zhi-Qiang Zhang
DYDe-Xin Yu
De-Xin Yu
CZCaiyun Zhong
Caiyun Zhong
Bladder cancer is a common genitourinary malignant disease worldwide. Convincing evidence shows that cigarette smoke (CS) is a crucial risk factor for bladder cancer, yet the role of the NF-κB signaling pathway in the development of CS-associated bladder cancer has not been fully elucidated. In the present study, we found that exposure to cigarette smoke extract (CSE) induced proliferation and triggered the transition of normal human urothelial cells from G1 to S phase. Moreover, CSE exposure enhanced the expression of cyclin D1 and proliferating cell nuclear antigen (PCNA) and decreased the expression of p21 in SV-HUC-1 cells. Furthermore, the levels of nuclear NF-κB p65/p50 were significantly elevated by CSE. Pre-treatment with the NF-κB inhibitor (PDTC) reversed CSE-triggered cell proliferation. Taken together, our study revealed that CSE induced proliferation of normal human urothelial cells through the NF-κB pathway, and these data enhance our understanding of the CSE-related carcinogenesis of bladder cancer.

13 May 2021 in Journal of Zhejiang University-SCIENCE B
Verified
Journal Article
Open access
PDF file
HGHao Geng
Hao Geng
QZQingchen Zhou
Qingchen Zhou
WGWenhao Guo
Wenhao Guo
LLLing Lu
Ling Lu
LBLiangkuan Bi
Liangkuan Bi
ZLZhaofeng Liang
Zhaofeng Liang
Exosomes are nanometer-sized vesicles that contain various types of biologically active components, including proteins, nucleic acids, carbohydrates, and l

23 December 2020 in Oncology Letters
Verified
Journal Article
Open access
PDF file
DWDengdian Wang
Dengdian Wang
DXDongdong Xie
Dongdong Xie
LBLiangkuan Bi
Liangkuan Bi
YWYi Wang
Yi Wang
CZCi Zou
Ci Zou
CZCaiyun Zhong
Caiyun Zhong
Substantial evidence suggests that cancer stem cells (CSCs) are the main cause of the initiation, progression and recurrence of tumors. Benzidine has been identified as a risk factor for bladder cancer. The aim of the present study was to investigate the effects of benzidine on bladder CSCs (BCSCs) and the possible mechanism underlying its action. The bladder cancer cell lines UM‑UC‑3 and EJ were maintained in serum‑free medium and cells forming three‑dimensional spheres were characterized as BCSCs. The sphere‑forming cells were exposed to different concentrations of benzidine and vismodegib, and western blotting was performed to evaluate the expression of markers associated with CSCs and the Sonic hedgehog (SHH) signaling pathway. Flow cytometry was used to detect the distribution of cells in different phases of the cell cycle, and immunofluorescence staining was used to detect the protein expression of CD44. The results revealed that the levels of BCSC markers, namely CD133, CD44, aldehyde dehydrogenase 1‑A1, Nanog and octamer‑binding transcription factor‑4, in the cell spheres were markedly elevated compared with those in cells cultured in serum‑supplemented medium. Furthermore, benzidine increased the expression of BCSC markers and promoted the sphere‑forming ability of the cells. In addition, it was observed that benzidine activated the SHH pathway, while inhibition of the Shh pathway using vismodegib diminished the promoting effects of benzidine on BCSCs. The findings of the present study indicate that benzidine promoted the stemness of BCSCs via activation of the SHH pathway, which may support further exploration of the molecular basis of the association between benzidine exposure and bladder oncogenesis.